AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...

AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...

In a “normal” electrocardiogram (ECG), the transition of the QRS axis in the precordial leads occurs between leads V 3 and V 4 (i.e., there is a dominant S in V 3 and a dominant R in V 4).

The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.